Company: INMB
Filing Date: 2025-12-03
Form Type: 8-K
Source: 0001213900-25-117828
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-12-03
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                              
         10.1      Amendment to Employment Agreement, dated December 2, 2025, between INmune Bio Inc. and David Moss        
         10.2      Amendment to Employment Agreement, dated December 2, 2025, between INmune Bio Inc. and Cory Ellspermann  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                             

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              INMUNE BIO INC.                               
  Date: December 3, 2025      By:                  /s/ David Moss           
                                                   David Moss               
                                                   Chief Executive Officer